A phase II clinical trial of CPI-613 (devimistat) in patients with relapsed or refractory burkitt lymphoma/leukemia or high-grade B-cell lymphoma with rearrangements of MYC and BCL2and/or BCL6 Meeting Abstract
| Authors: | Noy, A.; Pardee, T. S.; Nikolaenko, L.; Steiner, R. E.; Abramson, J. S.; Dunleavy, K.; Luther, S. |
| Abstract Title: | A phase II clinical trial of CPI-613 (devimistat) in patients with relapsed or refractory burkitt lymphoma/leukemia or high-grade B-cell lymphoma with rearrangements of MYC and BCL2and/or BCL6 |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164602110 |
| DOI: | 10.1182/blood-2019-131563 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4087 -- Source: Wos |
